ClinicalTrials.gg
Not yet recruitingNCT07818863COHUpdated Sep 14, 2026

Circles of Hope: Group Intervention for Adolescents With Suicidal Symptoms

An interventional study of Circles of Hope Group Psychotherapy in Suicidal Ideation, sponsored by University of Haifa. Not yet recruiting. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-14.

Sponsored by University of Haifa · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
12 Years to 18 Years
Sex
All
01

Study summary

This pilot study examines the feasibility, acceptability, and preliminary outcomes of a short-term group psychotherapy intervention for adolescents experiencing suicidal symptoms without immediate suicidal intent. The intervention is implemented within a public child and adolescent mental health clinic and includes emotional processing, interpersonal work, psychoeducation, and parental involvement. The study will evaluate participant engagement, attendance, and preliminary changes in suicidal ideation and related emotional and interpersonal functioning. The goal of the study is to contribute to the development of safe, feasible, and accessible group-based interventions for adolescents at suicide risk within public mental health services.

Read the detailed description

Adolescent suicidality represents a major clinical and public mental health challenge, with increasing rates of suicidal ideation and related emotional distress among youth. Although evidence-based psychotherapies for suicidal adolescents exist, many are resource-intensive and primarily delivered in individual formats, limiting their accessibility within public mental health systems.

This study examines a short-term group psychotherapy intervention ("Circles of Hope") developed for adolescents experiencing suicidal symptoms without immediate suicidal intent. The intervention is designed for implementation within routine public mental health services and aims to provide an accessible and structured therapeutic response for adolescents at suicide risk.

The intervention includes emotional processing, interpersonal group work, psychoeducational components, ongoing risk monitoring, and parental involvement. Groups are conducted in a small-group format within a child and adolescent mental health clinic.

The primary aim of this pilot study is to evaluate the feasibility and acceptability of the intervention, including recruitment, retention, attendance, and participant engagement. Secondary aims include preliminary examination of changes in suicidal ideation and related emotional and interpersonal outcomes.

Participants will complete assessments at baseline, post-intervention, and follow-up. Findings from this study are intended to contribute to the development of safe, feasible, and accessible group-based interventions for adolescents with suicidal symptoms in public mental health settings.

02

Conditions studied

  • Suicidal Ideation

Browse trials for

03

In context

Suicidal Ideation

569 studies on the registry are indexed under Suicidal Ideation; 203 are open to participants now.

This study's planned enrollment of 40 is below the median of 80 across 469 interventional studies indexed under Suicidal Ideation.

Browse Suicidal Ideation studies →

Lead sponsor

University of Haifa is the lead sponsor of 105 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents aged 12-18 years
  • Presence of suicidal symptoms or suicidal ideation
  • Ability to participate in a group psychotherapy intervention
  • Ability to provide informed assent and parental consent

Exclusion criteria

Exclusion Criteria:

  • Immediate suicidal intent requiring urgent hospitalization or intensive intervention
  • Acute psychotic symptoms or severe cognitive impairment interfering with group participation
  • Clinical condition preventing participation in a group setting, as determined by clinical assessment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Circles of Hope Group Intervention

    Participants will receive a short-term group psychotherapy intervention designed for adolescents experiencing suicidal symptoms without immediate suicidal intent. The intervention includes emotional processing, interpersonal group work, psychoeducational components, ongoing risk monitoring, and parental involvement within a public child and adolescent mental health clinic.

    Behavioral: Circles of Hope Group Psychotherapy

Interventions

  • BehavioralCircles of Hope Group Psychotherapy

    A short-term group psychotherapy intervention for adolescents experiencing suicidal symptoms without immediate suicidal intent. The intervention includes emotional processing, interpersonal group work, psychoeducational components, ongoing risk monitoring, and parental involvement within a public child and adolescent mental health clinic.

06

What researchers measure

Primary outcomes

  1. Suicidal Ideation - Suicidal Ideation Questionnaire (SIQ)

    Suicidal ideation will be assessed using the Suicidal Ideation Questionnaire (SIQ), a self-report measure assessing the frequency and intensity of suicidal thoughts.

    Time frame: Baseline and immediately post-intervention (after completion of the 8-session intervention)

  2. Suicidal Ideation - Scale for Suicide Ideation (SSI)

    Suicidal ideation will be assessed using the Scale for Suicide Ideation (SSI), which assesses cognitive and motivational aspects of suicidal ideation, including planning, wish to die, and perceived ability to act.

    Time frame: Baseline and immediately post-intervention (after completion of the 8-session intervention)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07818863
Responsible party
Sponsor
First posted
Sep 14, 2026
Start date
Nov 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Sep 14, 2026

Study contacts

Chen Mike, PhD Candidate
Contact
chenmik@gmail.com
+972506555008

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion